SCHEMBL4613631

SCHEMBL4613631

CCCCOc1cc(CCS(=O)(=O)NC(=O)OCc2ccccc2)n(Cc2ccc(Cl)cc2Cl)n1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4614162 0.92 PPARG (0.75) PPARG
SCHEMBL4612552 0.90 PPARG (0.75) PPARG
SCHEMBL4794725 0.90 PPARG (0.75) PPARG
SCHEMBL3212766 0.89 PPARG (0.77) PPARG
SCHEMBL4615849 0.88 PPARG (0.69) PPARG
SCHEMBL3208196 0.85 PPARG (0.91) PPARG
SCHEMBL3207288 0.84 PPARG (1.00) PPARG
SCHEMBL3217092 0.81 PPARG (1.00) PPARG
SCHEMBL3206879 0.81 PPARG (1.00) PPARG
SCHEMBL3205014 0.80 PPARG (1.00) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed